ASCO Genitourinary Cancers Symposium

 

ASCO Genitourinary Cancers Symposium
Avatar

Trials in Progress in Neoadjuvant Systemic Therapy in MIBC

By ASCO Genitourinary Cancers Symposium FEATURING Petros Grivas
By ASCO Genitourinary Cancers Symposium FEATURING Petros Grivas
197 views
March 16, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Videos
08:55

ASCO GU 2022: Community Oncologists’ Perceptions of and Barriers to …

ASCO Genitourinary Cancers Symposium

A. Gajra

77 views
09:36

ASCO GU 2022 on EV-103 Cohort H: Antitumor Activity of Neoadjuvant T…

ASCO Genitourinary Cancers Symposium

N. Mar

185 views
08:54

Trials in Progress in Neoadjuvant Systemic Therapy in MIBC

ASCO Genitourinary Cancers Symposium

P. Grivas

197 views
11:23

ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Pre…

ASCO Genitourinary Cancers Symposium

D. Spratt

45 views
12:14

ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up:…

ASCO Genitourinary Cancers Symposium

S. Tykodi

186 views
06:52

ASCO GU 2022: Tumor Mutational Burden as a Predictive Biomarker for …

ASCO Genitourinary Cancers Symposium

S. Gupta

70 views
20:27

ASCO GU 2022 on Radiation Therapy in Localized Prostate Cancer: Chan…

ASCO Genitourinary Cancers Symposium

A. Bossi

42 views
13:49

ASCO GU 2022 on Multi-Institutional Matched Comparison of Radical Cy…

ASCO Genitourinary Cancers Symposium

A. Zlotta

133 views
09:54

ASCO GU 2022 Updates on the Randomized Meet-URO12 Trial: Niraparib +…

ASCO Genitourinary Cancers Symposium

M. Di Maio

87 views
04:06

ASCO GU 2022 Updates on the Phase 3 TITAN Study: The Effect of Prior…

ASCO Genitourinary Cancers Symposium

K. Chi

169 views
10:53

ASCO GU 2022 TROPHY-U-01 Cohort 3: Sacituzumab Govitecan + Pembroliz…

ASCO Genitourinary Cancers Symposium

P. Grivas

113 views
05:41

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combinati…

Fred Saad

366 views
11:45

ASCO GU 2022 PROpel Phase III Trial Highlights: Olaparib & Abiratero…

ASCO Genitourinary Cancers Symposium

F. Saad

365 views
08:02

ASCO GU 2022 Updates on the ARIES Trial: 1L Avelumab in PD-L1+ Metas…

ASCO Genitourinary Cancers Symposium

R. Iacovelli

25 views
11:11

ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoad…

ASCO Genitourinary Cancers Symposium

D. Petrylak

160 views
07:47

ASCO GU 2022 on a Phase II Study of Nivo + Ipi for Advanced GU Malig…

ASCO Genitourinary Cancers Symposium

B. McGregor

90 views
11:32

ASCO GU 2022: Phase II/III Clinical Results of IL-15RαFc Superagonis…

ASCO Genitourinary Cancers Symposium

S. Chang

29 views
10:01

ASCO GU 2022 on Management of Toxicities With Novel Systemic Therapi…

ASCO Genitourinary Cancers Symposium

T. Flaig

30 views
07:12

ASCO GU 2022 on Bone Mineral Density in De Novo mCSPC Treated With/W…

ASCO Genitourinary Cancers Symposium

G. Roubaud

90 views
08:35

ASCO GU 2022 on 1L Axitinib + Pembro in Advanced RCC: Real-World Tre…

ASCO Genitourinary Cancers Symposium

Y. Zakharia

106 views
04:01

ASCO GU 2022 on Nivo + Cabo vs. Sunitinib for Advanced RCC: Final OS…

ASCO Genitourinary Cancers Symposium

T. Powles

259 views
05:00

ASCO GU 2022 OS in mHSPC Treated With Enzalutamide + ADT by High/Low…

ASCO Genitourinary Cancers Symposium

A. Armstrong

54 views
06:48

ASCO GU 2022 CABOSEQ Trial Updates on the Efficacy of Cabozantinib P…

ASCO Genitourinary Cancers Symposium

V. Navani

49 views
08:33

ASCO GU 2022 on the Immune Profiling of Advanced Prostate Cancer Har…

ASCO Genitourinary Cancers Symposium

M. Soleimani

160 views
05:43

ASCO GU 2022: A Phase I/II Study of Nivo & Axitinib in Patients With…

ASCO Genitourinary Cancers Symposium

M. Zibelman

34 views
06:49

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTUC: F…

ASCO Genitourinary Cancers Symposium

W. Yip

93 views
16:00

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

ASCO Genitourinary Cancers Symposium

M. Dean

192 views
07:40

ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic UC: Prel…

ASCO Genitourinary Cancers Symposium

V. Koshkin

130 views
09:23

ASCO GU 2022 on Molecular Alterations Across Sites of Metastasis in …

ASCO Genitourinary Cancers Symposium

R. McKay

78 views
07:53

ASCO GU 2022 Updates on Neoadjuvant Cabozantinib in Locally Advanced…

ASCO Genitourinary Cancers Symposium

M. Bilen

65 views
06:58

ASCO GU 2022 on the Updated OS Analysis for Docetaxel +/- Capivasert…

ASCO Genitourinary Cancers Symposium

S. Crabb

30 views
11:54

ASCO GU 2022 Efficacy & Safety of Continuing Enza in Chemo-Naïve mCR…

ASCO Genitourinary Cancers Symposium

A. Merseburger

67 views
03:02

ASCO GU 2022 on Pembro as Post-Nephrectomy Adjuvant Therapy for RCC:…

ASCO Genitourinary Cancers Symposium

T. Choueiri

121 views
07:45

ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CP…

ASCO Genitourinary Cancers Symposium

V. Grünwald

38 views
13:17

ASCO GU 2022 Highlights on the ADCs in Advanced Urothelial Cancer: C…

ASCO Genitourinary Cancers Symposium

S. Tagawa

165 views
05:16

ASCO GU 2022 Survival Outcomes and Characterization of Patients With…

ASCO Genitourinary Cancers Symposium

N. Sayegh

193 views
16:34

ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oli…

ASCO Genitourinary Cancers Symposium

N. Haas

146 views